Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Systemic Veins01:11

Overview of Systemic Veins

Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the middle...
Veins of Thorax01:19

Veins of Thorax

The azygos system is a crucial part of the body's circulatory system and drains most of the thorax. It comprises the azygos, hemiazygos, and accessory hemiazygos veins.
The azygos vein, positioned just right of the midline and anterior to the vertebral column, begins at the junction of the right ascending lumbar and subcostal veins, terminating in the superior vena cava. This vein drains blood from the right side of the thoracic wall, thoracic viscera, and posterior abdominal wall.
The...
Veins of the Abdomen and Pelvis01:18

Veins of the Abdomen and Pelvis

The human body is a complex system of interconnected parts, and the circulatory system plays a crucial role in maintaining overall health. One key component of this system is the inferior vena cava, a large vein responsible for returning blood from the abdominopelvic viscera and abdominal walls to the heart.
The inferior vena cava is fed by numerous smaller veins. The lumbar veins, for instance, drain the posterior abdominal wall, emptying both directly into the inferior vena cava and into the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue factor-bearing extracellular vesicles, procoagulant phospholipids and D-dimer as potential biomarkers for venous thromboembolism in patients with newly diagnosed multiple myeloma: A comprehensive analysis.

Thrombosis research·2025
Same author

Platelet transfusion in adults: An update.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2022
Same author

Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey.

The Journal of hospital infection·2020
Same author

Superficial thrombophlebitis of the legs: still a lot to learn. Reply to a rebuttal.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study.

Journal of thrombosis and haemostasis : JTH·2016
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Inferior vena cava interruption: how and when?

P Girard1, B Tardy, H Decousus

  • 1Département Thoracique, Institut Mutualiste Montsouris, Paris, France. pgirard@imm.fr

Annual Review of Medicine
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Inferior vena cava (IVC) filters help prevent pulmonary embolism but lack robust data on effectiveness and safety. A trial showed no mortality benefit and an increased risk of deep venous thrombosis.

More Related Videos

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava
06:59

Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava

Published on: January 13, 2023

Related Experiment Videos

Last Updated: May 11, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava
06:59

Image Acquisition Method for the Sonographic Assessment of the Inferior Vena Cava

Published on: January 13, 2023

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Pulmonary Medicine

Background:

  • Inferior vena cava (IVC) interruption using filters is a common procedure to prevent pulmonary embolism (PE) from lower extremity deep vein thrombosis (DVT).
  • Despite widespread use for three decades, comprehensive data on the efficacy and safety of IVC filters remain limited.
  • Existing literature suggests a need for better patient selection and understanding of filter performance.

Purpose of the Study:

  • To evaluate the effectiveness and safety of IVC filters in preventing PE.
  • To analyze the impact of IVC filters on mortality and recurrent DVT.
  • To classify indications for IVC interruption and identify areas for future research.

Main Methods:

  • The study references the first controlled clinical trial on IVC filters.
  • Analysis of existing literature to categorize indications for IVC interruption.
  • Review of data on filter efficacy, safety, mortality, and recurrent DVT.

Main Results:

  • The first controlled clinical trial demonstrated IVC filters' effectiveness in preventing PE.
  • IVC filters showed no significant impact on patient mortality.
  • An increased risk of recurrent deep venous thrombosis was observed in patients with IVC filters.

Conclusions:

  • While IVC filters can be effective, their overall benefit requires further investigation.
  • Current indications for IVC interruption range from accepted to debatable, necessitating refined criteria.
  • Future prospective studies should focus on identifying high-risk patients and selecting optimal filters.